Corteva, Inc. (CTVA) Stock Price & How to Invest

Corteva is one of the largest agricultural input companies in the world, formed in 2019 when DowDuPont spun off its agriculture business. The company operates two main segments. Seed develops and sells genetically improved corn, soybean, canola, and other crop seeds. Crop Protection develops and sells herbicides, insecticides, fungicides, and biological products to protect crops from weeds, insects, and diseases.

Corteva is the largest pure-play agricultural input company on US markets after Monsanto was acquired by Bayer. The pure-play structure means revenue and earnings move directly with farmer income and commodity crop prices, providing cleaner exposure to agricultural cycles than diversified peers. Headquartered in Indianapolis, Indiana. Chuck Magro has been CEO since 2021.

Commodity crop price cycles affect farmer purchasing power and Corteva revenue. Weather conditions affect crop years and product demand. Regulatory pressure on certain herbicides (atrazine, paraquat) creates product-level risks.

20 analysts publish price targets on CTVA, averaging $92.10 against a $87.73 price as of September 2026, or +5.0%. The published targets run from $78.00 to $103.00, a narrow spread, and the ratings split 15 buy, 6 hold, 0 sell. Over the last six months there have been 10 raises and 2 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full CTVA forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

We give no verdict on Corteva, Inc.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Seed technology pipeline. Corteva continues to advance seed traits (drought tolerance, herbicide tolerance, insect resistance, yield improvements). The most optimistic published target, $103.00, assumes this works close to its best case.

The case against. Commodity crop price cycles affect farmer purchasing power and Corteva revenue. The most pessimistic target, $78.00, is roughly what CTVA is worth if this bites instead.

Read the full bull and bear case on CTVA, including what would have to change to break either one. Walnut is not an investment adviser.

No. Corteva, Inc. (CTVA) has not split its stock in the last 10 years. That is a statement about the window we check rather than about the company’s entire history, so an older split is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Corteva, Inc.'s investor relations page or your broker.

• Revenue (TTM): ~$17 billion
• Operating margin: ~13%
• Net income (TTM): ~$1.5 billion
• EPS (TTM): ~$2.20
• P/E (TTM): ~30x
• Price to sales: ~2.5x
• Dividend yield: ~1.0%, with steady growth
• Free cash flow: ~$1.5 billion annually
• Seed segment: Larger and more profitable than crop protection

Corteva trades at a premium to traditional chemicals and materials peers reflecting the pure-play agricultural input exposure, the durable seed franchise, and the biologicals growth story. The multiple compresses during commodity crop downturns when farmer income weakens.

If you want CTVA exposure as part of a larger bundle rather than directly, these ETFs hold it meaningfully. Weights are approximate and refresh quarterly.

These are the investment theses CTVA naturally fits into. Each links to a full theme guide listing every other stock that belongs and the ETFs commonly used as a passive proxy.

Other names that sit close to CTVA: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. Worth a look if you are thinking about diversification within a thesis rather than concentration on one ticker.

There are three common ways to get CTVA exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it (MOO, IWS, XLB), which spreads the position across many companies. Or build it into a focused thematic portfolio, so CTVA sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where CTVA fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

Corteva (CTVA) gives clean exposure to the agricultural cycle, with the higher-margin Seed segment and biologicals growth offsetting commodity-driven swings in crop protection. In a portfolio it acts as a cyclical materials and agriculture holding, often paired with Deere (DE) as the input layer to Deere's equipment layer, competing with Bayer, BASF, Syngenta, and FMC, and sensitive to crop prices, weather, and herbicide regulation.

Whether CTVA is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is CTVA a buy or a sell?, and where the stock could go from here in the CTVA stock forecast.

For income investors, whether CTVA pays a dividend and how the payout looks is covered in does CTVA pay a dividend? And to weigh CTVA against a peer, read the full side-by-side comparisons: CTVA vs DE and CTVA vs CALM.